Literature DB >> 2121943

Photothermal sensitizers: possible use in tumor therapy.

G Jori1, J D Spikes.   

Abstract

Photothermal damage of tissues or endotissular compartments may be induced by pulsed irradiation of either endogenous chromophores (e.g. hemoglobin, melanin) or externally added dyes; the latter should have short triplet lifetimes and mainly decay from electronically excited states by nonradiative pathways. Potential photothermal sensitizers are some metallo derivatives of porphyrins and porphyrinoid compounds, azo dyes and triphenylmethane derivatives. These dyes have the additional property of significant absorbance at wavelengths longer than 600 nm, which can penetrate deep into biological tissues. Spatial confinement of the photothermal process depends on the absorption coefficient of the photoexcited chromophore and its thermal relaxation time. Present evidence indicates that the selective photothermal damage of macromolecules or subcellular organelles requires pulsed excitation at picosecond or nanosecond regimes, while microsecond or millisecond domains are effective in the case of cells or similar structures. The possible use of photothermal sensitization in the treatment of tumors is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121943     DOI: 10.1016/1011-1344(90)85078-b

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  10 in total

Review 1.  Development and applications of photo-triggered theranostic agents.

Authors:  Prakash Rai; Srivalleesha Mallidi; Xiang Zheng; Ramtin Rahmanzadeh; Youssef Mir; Stefan Elrington; Ahmat Khurshid; Tayyaba Hasan
Journal:  Adv Drug Deliv Rev       Date:  2010-09-19       Impact factor: 15.470

Review 2.  Plasmonic photothermal therapy (PPTT) using gold nanoparticles.

Authors:  Xiaohua Huang; Prashant K Jain; Ivan H El-Sayed; Mostafa A El-Sayed
Journal:  Lasers Med Sci       Date:  2007-08-03       Impact factor: 3.161

3.  Target-selective phototherapy using a ligand-based photosensitizer for type 2 cannabinoid receptor.

Authors:  Shaojuan Zhang; Ningyang Jia; Pin Shao; Qin Tong; Xiang-Qun Xie; Mingfeng Bai
Journal:  Chem Biol       Date:  2014-02-27

Review 4.  Shedding light on nanomedicine.

Authors:  Rong Tong; Daniel S Kohane
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-08-09

Review 5.  Physical energy for drug delivery; poration, concentration and activation.

Authors:  Shanmugamurthy Lakshmanan; Gaurav K Gupta; Pinar Avci; Rakkiyappan Chandran; Magesh Sadasivam; Ana Elisa Serafim Jorge; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2013-06-07       Impact factor: 15.470

Review 6.  MRI-guided monitoring of thermal dose and targeted drug delivery for cancer therapy.

Authors:  Ruchika Fernando; Jon Downs; Danny Maples; Ashish Ranjan
Journal:  Pharm Res       Date:  2013-06-19       Impact factor: 4.200

7.  Phototheranostic Porphyrin Nanoparticles Enable Visualization and Targeted Treatment of Head and Neck Cancer in Clinically Relevant Models.

Authors:  Nidal Muhanna; Cheng S Jin; Elizabeth Huynh; Harley Chan; Yi Qiu; Wenlei Jiang; Liyang Cui; Laura Burgess; Margarete K Akens; Juan Chen; Jonathan C Irish; Gang Zheng
Journal:  Theranostics       Date:  2015-10-18       Impact factor: 11.556

Review 8.  Non-Oncologic Applications of Nanomedicine-Based Phototherapy.

Authors:  Su Woong Yoo; Gyungseok Oh; Jin Chul Ahn; Euiheon Chung
Journal:  Biomedicines       Date:  2021-01-25

9.  Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly.

Authors:  Cheng S Jin; Jonathan F Lovell; Juan Chen; Gang Zheng
Journal:  ACS Nano       Date:  2013-02-12       Impact factor: 15.881

10.  EGFR-targeted delivery of DOX-loaded Fe3O4@ polydopamine multifunctional nanocomposites for MRI and antitumor chemo-photothermal therapy.

Authors:  Xupeng Mu; Fuqiang Zhang; Chenfei Kong; Hongmei Zhang; Wenjing Zhang; Rui Ge; Yi Liu; Jinlan Jiang
Journal:  Int J Nanomedicine       Date:  2017-04-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.